When the new Republican听House majority gets to work next year, they will likely continue their rhetoric of repeal and, perhaps, even vote on it. The media attention they receive for these actions may satisfy the GOP base, but with Democratic control of the Senate and presidency, actual repeal is extremely unlikely. In addition, Americans . More importantly, so do key interest groups.

It shouldn’t be a surprise that hospitals, insurers, large employers, and the pharmaceutical industry do not favor repeal. The health law took the shape it did for a reason: interest groups were reasonably successful in achieving their goals with respect to the fundamental structure of the law. Insurers and hospitals (even if Americans oppose it) because it promises greater revenue and a more attractive risk pool for the former and a reduction in uncompensated care for the latter. The pharmaceutical industry is because it will lead to increased drug sales. that will reduce costs and increase quality, both for Medicare and for the supplements that large employers sponsor for their retirees.

If these interest groups opposed health reform, they would have killed it last winter, if not earlier. They didn’t. It’s unlikely the听Republican House leadership will take tangible steps to cross them now, despite what they say.

However, just because health reform won’t be repealed, that doesn’t mean there might not be significant changes during implementation, or that Republicans won’t have influence over those changes. Many of the key implementation decisions won’t be made at the federal level because insurance is regulated to a large extent by .听State insurance commissioners are not appointed by the president or by Congress; they are generally appointed by governors.听In the November mid-term elections, Republicans听, and will, as a result, control that office in 29 states. And, in the states where insurance commissioner is an elected position, the GOP also made gains.

The exchanges, which still have to be set up, are听, as are Medicaid programs.听State insurance commissioners will have a lot of power and control to set regulations on how the exchanges will work.听That will make a big difference in how reform functions in the individual insurance market 聳 where many of the uninsured are expected to get insurance.

While the overhaul sets national standards for minimum benefits that insurers must offer in the exchanges, them. States could demand that insurers meet certain criteria, such as benefits requirements, or decline to set any at all.听Each state will also have to determine whether to administer the exchange itself, let a private entity do so, or decline entirely and submit to federal intervention. Additionally, the law provides states much leeway in determining what is an “unreasonable” premium increase. States could go as far as to refuse any increases without justification, or merely require justification only for severe increases, and then, perhaps, after the fact.听 The medical loss ratio can be changed on a state-by-state basis with approval from the Department of Health and Human Services.

Finally, it’s important to remember that Medicaid is a state-run program, and how changes are made to contain costs within it is entirely at the discretion of governors and their state legislatures. As we’ve already seen in the news, Republican governors of some states are seeking flexibility to significantly modify their states’ Medicaid program.

No one should be under the illusion that health reform is complete just because a law was passed last March. The degree to which objectives of the law are realized continues to depend on implementation. In contrast to the rhetoric from newly elected or re-elected Republican members of the House, or the intense media attention they enjoy, legislative action and implementation will be constrained and shaped by interested groups and action by the states. That doesn’t by any means guarantee success or imply certain failure; it means only that the game has changed. Congress may still be in it, but many other players, some at the state level, are now also on the field.

Austin Frakt is a health economist and an Assistant Professor of Health Policy and Management at Boston University’s School of Public Health.
Aaron Carroll is
associate professor of Pediatrics, the associate director of
听
Children’s Health Services Research
,
and
the director of the Center for Health Policy and Professionalism Research at Indiana University School of Medicine.听B
oth blog at
听





.

This <a target="_blank" href="/news/120610fraktcarroll/">article</a&gt; first appeared on <a target="_blank" href="">麻豆女优 Health News</a> and is republished here under a <a target="_blank" href=" Commons Attribution-NonCommercial-NoDerivatives 4.0 International License</a>.<img src="/wp-content/uploads/sites/8/2023/04/kffhealthnews-icon.png?w=150&quot; style="width:1em;height:1em;margin-left:10px;">